Tenax Therapeutics Inc (NASDAQ:TENX)

During the Trading Day
3.58 +0.07 / +1.99%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.64 +0.06 / +1.68%
 
Volume: 100.00
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$98.7M

Company Description

Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market. Its business objective is to discover, develop, and commercialize novel therapeutic products for disease indications that represent significant areas of clinical need and commercial opportunity. In addition, the company has commercialized its Dermacyte line of skin care cosmetics for the anti-aging market. Tenax Therapeutics was founded on May 26, 1967 and is headquartered in Morrisville, NC.

Contact Information

Tenax Therapeutics, Inc.
One Copley Parkway
Morrisville North Carolina 27560
P:(919) 855-2100
Investor Relations:

Employees

Shareholders

Mutual fund holders4.69%
Other institutional35.09%
Individual stakeholders0.32%

Top Executives

John P. KelleyChief Executive Officer & Director
Michael B. JebsenPresident, Chief Financial Officer & Treasurer
Paula BokeschChief Medical Officer
Doug RandallExecutive VP-Business & Commercial Operations
Nancy J. HecoxSecretary, SVP-Legal Affairs & General Council

To view my watchlist

Not a member yet?

Sign up now for a free account